SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-22-000059
Filing Date
2022-11-08
Accepted
2022-11-08 16:10:10
Documents
89
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q halo-20220930.htm   iXBRL 10-Q 2151475
2 EX-10.3 ex103-severancepolicy.htm EX-10.3 5693
3 EX-10.4 ex104halozymetherapeuticsi.htm EX-10.4 232105
4 EX-31.1 ex31110qq32022.htm EX-31.1 13059
5 EX-31.2 ex31210qq32022.htm EX-31.2 12999
6 EX-32 ex3210qq32022.htm EX-32 13925
12 halo-20220930_g1.jpg GRAPHIC 115565
13 halo-20220930_g2.jpg GRAPHIC 103577
  Complete submission text file 0001159036-22-000059.txt   10583067

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20220930.xsd EX-101.SCH 55235
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20220930_cal.xml EX-101.CAL 101752
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20220930_def.xml EX-101.DEF 312830
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20220930_lab.xml EX-101.LAB 702108
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20220930_pre.xml EX-101.PRE 489768
83 EXTRACTED XBRL INSTANCE DOCUMENT halo-20220930_htm.xml XML 1875901
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 221368960
SIC: 2836 Biological Products, (No Diagnostic Substances)